Central asia

324 views
277 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
324
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Central asia

  1. 1. GROUP WORK Kazakhstan Kyrgyzstan Tajikistan Turkmenistan Uzbekistan Facilitator: Rita ColumbiaWorking Meeting on Comprehensive Cervical Cancer Prevention and Control in UNFPA EECARO and ASRO countries Antalya, Turkey May 18-20
  2. 2. Group work by teams of countries Session I: Success stories and challenges1) ADVOCACYi)Target groups:Politicians, decision makers, health providers,communities, women, religious leadersii) Key messages for each target group:Evidence based, clear, short, informative messagesbased on cultural peculiaritiesiii) How can messages be delivered: All existing communication channels
  3. 3. ADVOCACY How can we mobilize communitiesChallenges Opportunities • Limited financial resources • Evidence based for advocacy information • Low awareness of • Health promotion centers population about CxCa • Local NGOs • Gender issues • International organizations • Hard to reach population • Professional associations
  4. 4. VACCINES •CHALLENGES Resistance from parents OPPORTUNITIES due to safety concerns • Low level of knowledge • Existing immunization and skills of health programs providers • Support of decision • Experience and results of pilot projects makers • Sustainability – donor • GAVI eligibility? driven
  5. 5. SCREENING & TREATMENTCHALLENGES OPPORTUNITIES • Some countries don’t have CxCa control & prevention programs • Existing health infrastructure • Most countries don’t have (Kazakhstan & Uzbekistan) population based Cxca registry • Donor support (scaling up pilot • There’s no unified approach to projects) CxCa prevention & control • National programs on CxCa control • Lack of recourses (human and & prevention (Kazakhstan, financial) Turkmenistan, Tajikistan) • Poor infrastructure • Population based cancer registries • CxCa prevention measures are not integrated in to PHC

×